We now run a digital biomarker initiative called the Early Detection of FTD (EDoF) study. This aims to develop a series of measures that may be useful for diagnosis and for home monitoring, particularly as outcome measures in trials. It acts as an incubator of ideas that we can then translate into the GENFI study, and currently includes:
Testing a novel methodology that involves passively measuring smartphone use – a collaborative project with Applied Cognition
Detailed cognitive testing using a computerised battery on a tablet called Ignite